Abeta retroparticles (University of Heidelberg/Novartis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAbeta retroparticles (University of Heidelberg/Novartis)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Recombinant vector vaccineBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Therapeutic vaccine

Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsBeta amyloid A4 protein modulators

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Heidelberg

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Institutes For Biomedical Research Inc University Of Heidelberg

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A